Researchers from Bar-Ilan University and the University of Edinburgh were able to characterize for the first time changes in early-stage Alzheimer’s disease that occur inside individual brains. Results from the study published in the journal Neuron suggest that Alzheimer’s-affected cells result in a reduction of electrical activity throughout…
The non-governmental organization American Association of Retired Persons (AARP) will host over 40 screenings of the Oscar-winning drama “Still Alice” in collaboration with Sony Pictures Home Entertainment. The screenings will take place nationwide between May and June and are coinciding with the release of the film to DVD and Blu-Ray on…
In a new study entitled “Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease,” researchers established the molecular structure of a key form of amyloid-β (Aβ) protein, Aβ42. This finding allows researchers to understand how Aβ42 accumulates in plaque aggregates in the brain of…
In a recent study published in the journal Alzheimer’s Research & Therapy, a team of researchers from the University of British Columbia discovered that a novel drug for epilepsy might lead to a potential a treatment for Alzheimer’s disease. The study results support the theory that…
In a recent study published in The Journal of Clinical Investigation, a team of researchers at the Washington University School of Medicine in St. Louis found an association between Alzheimer’s disease and diabetes, which provides evidence on the fact the Alzheimer’s may be affected by…
NuevaCare recently announced that it will be presenting MnemeTherapy®, its service to address Alzheimer’s disease, at two upcoming seminars. The first will be held on Wednesday, May 6 at the PSA Annual Regional Stroke Conference at The Magnolia of Millbrae; the second will take place on Wednesday, May 13 at the Dementia…
A recent meeting convened by the National Institutes of Health (NIH) could dramatically alter how researchers study Alzheimer’s disease (AD). The NIH issued new recommendations, based on the recent Alzheimer’s Disease Research Summit, which could speed up work leading to the development of treatments for AD. During the summit, more…
CereSpir™ Incorporated, a biotechnology company firm advancing CSP-1103, which is a first-in-class modulator of the innate immune system of the brain to address treatment for Alzheimer’s disease, recently announced that Sophie Egholm has been appointed as Chief Operating Officer of the company. Egholm is a pharmacologist and medicinal chemist who has spent her…
A team of researchers from the University of California, San Diego School of Medicine and Cenna Biosciences, Inc. were able to identify in mice, compounds that inhibit the production of beta amyloid peptides. The results published in the journal PLOS ONE may offer a potential early intervention for…
Samsung Tomorrow, the Samsung Electronics Official Global Blog, reports that about a year ago Samsung Electronics Tunisia (SETN) marketing manager for mobile products Azer Jaafoura and several colleagues began developing a smartphone app for helping out Alzheimer’s Disease (AD) patients. “We wanted to make life easier for Alzheimer’s patients…
Get regular updates to your inbox.